 | • レポートコード：GIR-22F20810 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Metastatic Cancer Treat Drug Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の転移性がん治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 転移性がん治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・化学療法剤、標的治療剤 アプリケーション別セグメントは次のように区分されます。 ・病院、診療所、その他 世界の転移性がん治療薬市場の主要な市場プレーヤーは以下のとおりです。 ・Roche、Merck、Johnson and Johnson、Eli Lilly、Sun Pharmaceutical、Bayer、Gilead Sciences、GlaxoSmithKline、Novartis、Pfizer、AstraZeneca 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、転移性がん治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な転移性がん治療薬メーカーの企業概要、2019年～2022年までの転移性がん治療薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な転移性がん治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別転移性がん治療薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの転移性がん治療薬のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での転移性がん治療薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および転移性がん治療薬の産業チェーンを掲載しています。 ・第13、14、15章では、転移性がん治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 転移性がん治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：化学療法剤、標的治療剤 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所、その他 - 世界の転移性がん治療薬市場規模・予測 - 世界の転移性がん治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Roche、Merck、Johnson and Johnson、Eli Lilly、Sun Pharmaceutical、Bayer、Gilead Sciences、GlaxoSmithKline、Novartis、Pfizer、AstraZeneca ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：化学療法剤、標的治療剤 ・アプリケーション別分析2017年-2028年：病院、診療所、その他 ・転移性がん治療薬の北米市場分析 - 転移性がん治療薬の北米市場：タイプ別市場規模2017年-2028年 - 転移性がん治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・転移性がん治療薬のヨーロッパ市場分析 - ：転移性がん治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：転移性がん治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・転移性がん治療薬のアジア太平洋市場分析 - 転移性がん治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 転移性がん治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・転移性がん治療薬の南米市場分析 - 転移性がん治療薬の南米市場：タイプ別市場規模2017年-2028年 - 転移性がん治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・転移性がん治療薬の中東・アフリカ市場分析 - 転移性がん治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 転移性がん治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Metastatic Cancer Treat Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Metastatic Cancer Treat Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Metastatic Cancer Treat Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemotherapy Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Metastatic Cancer Treat Drug include Roche, Merck, Johnson and Johnson, Eli Lilly, and Sun Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Metastatic Cancer Treat Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy Drugs
Targeted Therapy Drugs
Market segment by Application can be divided into
Hospitals
Clinics
Other
The key market players for global Metastatic Cancer Treat Drug market are listed below:
Roche
Merck
Johnson and Johnson
Eli Lilly
Sun Pharmaceutical
Bayer
Gilead Sciences
GlaxoSmithKline
Novartis
Pfizer
AstraZeneca
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metastatic Cancer Treat Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metastatic Cancer Treat Drug, with price, sales, revenue and global market share of Metastatic Cancer Treat Drug from 2019 to 2022.
Chapter 3, the Metastatic Cancer Treat Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metastatic Cancer Treat Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Metastatic Cancer Treat Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metastatic Cancer Treat Drug.
Chapter 13, 14, and 15, to describe Metastatic Cancer Treat Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Metastatic Cancer Treat Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metastatic Cancer Treat Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Chemotherapy Drugs
1.2.3 Targeted Therapy Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Metastatic Cancer Treat Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Metastatic Cancer Treat Drug Market Size & Forecast
1.4.1 Global Metastatic Cancer Treat Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Metastatic Cancer Treat Drug Sales in Volume (2017-2028)
1.4.3 Global Metastatic Cancer Treat Drug Price (2017-2028)
1.5 Global Metastatic Cancer Treat Drug Production Capacity Analysis
1.5.1 Global Metastatic Cancer Treat Drug Total Production Capacity (2017-2028)
1.5.2 Global Metastatic Cancer Treat Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Metastatic Cancer Treat Drug Market Drivers
1.6.2 Metastatic Cancer Treat Drug Market Restraints
1.6.3 Metastatic Cancer Treat Drug Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Metastatic Cancer Treat Drug Product and Services
2.1.4 Roche Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Metastatic Cancer Treat Drug Product and Services
2.2.4 Merck Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Metastatic Cancer Treat Drug Product and Services
2.3.4 Johnson and Johnson Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Metastatic Cancer Treat Drug Product and Services
2.4.4 Eli Lilly Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sun Pharmaceutical
2.5.1 Sun Pharmaceutical Details
2.5.2 Sun Pharmaceutical Major Business
2.5.3 Sun Pharmaceutical Metastatic Cancer Treat Drug Product and Services
2.5.4 Sun Pharmaceutical Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Metastatic Cancer Treat Drug Product and Services
2.6.4 Bayer Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Gilead Sciences
2.7.1 Gilead Sciences Details
2.7.2 Gilead Sciences Major Business
2.7.3 Gilead Sciences Metastatic Cancer Treat Drug Product and Services
2.7.4 Gilead Sciences Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Metastatic Cancer Treat Drug Product and Services
2.8.4 GlaxoSmithKline Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Metastatic Cancer Treat Drug Product and Services
2.9.4 Novartis Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Metastatic Cancer Treat Drug Product and Services
2.10.4 Pfizer Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Metastatic Cancer Treat Drug Product and Services
2.11.4 AstraZeneca Metastatic Cancer Treat Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Metastatic Cancer Treat Drug Breakdown Data by Manufacturer
3.1 Global Metastatic Cancer Treat Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Metastatic Cancer Treat Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Metastatic Cancer Treat Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Metastatic Cancer Treat Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Metastatic Cancer Treat Drug Manufacturer Market Share in 2021
3.5 Global Metastatic Cancer Treat Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Metastatic Cancer Treat Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Metastatic Cancer Treat Drug Market Size by Region
4.1.1 Global Metastatic Cancer Treat Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Metastatic Cancer Treat Drug Revenue by Region (2017-2028)
4.2 North America Metastatic Cancer Treat Drug Revenue (2017-2028)
4.3 Europe Metastatic Cancer Treat Drug Revenue (2017-2028)
4.4 Asia-Pacific Metastatic Cancer Treat Drug Revenue (2017-2028)
4.5 South America Metastatic Cancer Treat Drug Revenue (2017-2028)
4.6 Middle East and Africa Metastatic Cancer Treat Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Metastatic Cancer Treat Drug Sales in Volume by Type (2017-2028)
5.2 Global Metastatic Cancer Treat Drug Revenue by Type (2017-2028)
5.3 Global Metastatic Cancer Treat Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Metastatic Cancer Treat Drug Sales in Volume by Application (2017-2028)
6.2 Global Metastatic Cancer Treat Drug Revenue by Application (2017-2028)
6.3 Global Metastatic Cancer Treat Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Metastatic Cancer Treat Drug Sales by Type (2017-2028)
7.2 North America Metastatic Cancer Treat Drug Sales by Application (2017-2028)
7.3 North America Metastatic Cancer Treat Drug Market Size by Country
7.3.1 North America Metastatic Cancer Treat Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Metastatic Cancer Treat Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Metastatic Cancer Treat Drug Sales by Type (2017-2028)
8.2 Europe Metastatic Cancer Treat Drug Sales by Application (2017-2028)
8.3 Europe Metastatic Cancer Treat Drug Market Size by Country
8.3.1 Europe Metastatic Cancer Treat Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Metastatic Cancer Treat Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Metastatic Cancer Treat Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Metastatic Cancer Treat Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Metastatic Cancer Treat Drug Market Size by Region
9.3.1 Asia-Pacific Metastatic Cancer Treat Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Metastatic Cancer Treat Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Metastatic Cancer Treat Drug Sales by Type (2017-2028)
10.2 South America Metastatic Cancer Treat Drug Sales by Application (2017-2028)
10.3 South America Metastatic Cancer Treat Drug Market Size by Country
10.3.1 South America Metastatic Cancer Treat Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Metastatic Cancer Treat Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Metastatic Cancer Treat Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Metastatic Cancer Treat Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Metastatic Cancer Treat Drug Market Size by Country
11.3.1 Middle East & Africa Metastatic Cancer Treat Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Metastatic Cancer Treat Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Metastatic Cancer Treat Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Metastatic Cancer Treat Drug
12.3 Metastatic Cancer Treat Drug Production Process
12.4 Metastatic Cancer Treat Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Metastatic Cancer Treat Drug Typical Distributors
13.3 Metastatic Cancer Treat Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer